GT Biopharma (GTBP) Institutional Ownership → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free GTBP Stock Alerts $3.10 -0.13 (-4.02%) (As of 04:27 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)CurrentInstitutional OwnershipPercentage8.15%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$5.58MNumber ofInstitutional Sellers(last 12 months)0 Get GTBP Insider Trade Alerts Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GTBP Institutional Buying and Selling by Quarter Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> GT Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/2/2023Bank of Montreal Can596,240$262K0.0%N/A1.596% 1/23/2023 Baskin Financial Services Inc.151,354$134K0.0%N/A0.466% 11/7/2022Virtu Financial LLC24,864$44K0.0%N/A0.076% 5/5/2022Russell Investments Group Ltd.11,007$31K0.0%N/A0.033% 5/2/2022 Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078% 4/20/2022 Sigma Planning Corp21,400$62K0.0%N/A0.067% Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/14/2022Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114% 2/9/2022 Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098% 2/4/2022 Crumly & Associates Inc.32,163$85K0.0%N/A0.105% 2/3/2022Brighton Jones LLC11,288$34K0.0%N/A0.037% 1/31/2022Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036% 11/16/2021Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242% 11/16/2021Two Sigma Investments LP162,823$1.10M0.0%N/A0.771% 11/15/2021Marshall Wace LLP16,577$112K0.0%-35.7%0.078% 11/15/2021Franklin Resources Inc.28,500$192K0.0%N/A0.135% 11/12/2021Renaissance Technologies LLC84,700$571K0.0%N/A0.401% 11/12/2021Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008% 11/10/2021Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248% 11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468% 11/8/2021State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086% 11/8/2021Russell Investments Group Ltd.9,642$64K0.0%N/A0.046% 11/5/2021 Welch Group LLC10,000$67K0.0%N/A0.047% 11/4/2021Deutsche Bank AG11,400$77K0.0%-25.7%0.054% 11/2/2021New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039% 8/25/2021Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/17/2021Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042% 8/17/2021MetLife Investment Management LLC11,471$178K0.0%N/A0.054% 8/17/2021Citadel Advisors LLC510,058$7.91M0.0%N/A2.414% 8/16/2021California State Teachers Retirement System32,878$510K0.0%N/A0.156% 8/16/2021Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274% 8/16/2021State Street Corp374,704$5.81M0.0%N/A1.773% 8/16/2021Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389% 8/16/2021Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/13/2021Northern Trust Corp225,457$3.50M0.0%+555.6%1.067% 8/13/2021Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641% 8/13/2021Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649% 8/12/2021Legal & General Group Plc2,524$39K0.0%N/A0.012% 8/12/2021JPMorgan Chase & Co.9,155$142K0.0%N/A0.043% 8/12/2021The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065% 8/11/2021 Bank of New York Mellon Corp58,711$910K0.0%N/A0.278% Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690% 8/11/2021Deutsche Bank AG15,349$237K0.0%N/A0.073% 8/10/2021Citigroup Inc.6,134$95K0.0%N/A0.029% 8/6/2021Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009% 8/5/2021Rhumbline Advisers18,634$289K0.0%N/A0.088% 8/2/2021New York State Common Retirement Fund20,400$316K0.0%N/A0.097% 8/2/2021Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014% 7/31/2021 Davy Global Fund Management Ltd35,113$544K0.1%+33.4%0.166% 7/15/2021 Compagnie Lombard Odier SCmA15,000$233K0.0%N/A0.071% 7/6/2021 Silverleafe Capital Partners LLC104,000$1.61M0.6%N/A0.492% 5/19/2021Virtu Financial LLC22,741$156K0.0%N/A0.080% 5/19/2021Squarepoint Ops LLC16,543$113K0.0%N/A0.058% 5/18/2021Millennium Management LLC27,895$191K0.0%N/A0.098% 5/17/2021Royal Bank of Canada24,542$167K0.0%N/A0.086% 5/12/2021Northern Trust Corp34,387$235K0.0%N/A0.121% 5/12/2021Geode Capital Management LLC130,388$891K0.0%N/A0.459% 5/12/2021UBS Group AG3,918$27K0.0%N/A0.014% 5/11/2021 Davy Global Fund Management Ltd26,321$180K0.0%N/A0.093% (Data available from 1/1/2016 forward) GTBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GTBP shares? During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: Bank of Montreal Can ($262K), and Baskin Financial Services Inc. ($134K), Virtu Financial LLC ($44K).Learn more on GTBP's institutional investors. What percentage of GT Biopharma stock is owned by institutional investors? 8.15% of GT Biopharma stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings. Which institutional investors have been buying GT Biopharma stock? The following institutional investors have purchased GT Biopharma stock in the last 24 months: Bank of Montreal Can ($596.24K), Baskin Financial Services Inc. ($151.35K), and Virtu Financial LLC ($24.86K). How much institutional buying is happening at GT Biopharma? Institutional investors have bought a total of 772,458 shares in the last 24 months. This purchase volume represents approximately $10.92M in transactions. Related Companies: Longeveron Major Shareholders Exicure Major Shareholders Genprex Major Shareholders Ensysce Biosciences Major Shareholders NexImmune Major Shareholders Petros Pharmaceuticals Major Shareholders Bright Minds Biosciences Major Shareholders Soligenix Major Shareholders Seelos Therapeutics Major Shareholders ZyVersa Therapeutics Major Shareholders This page (NASDAQ:GTBP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
